RNA vaccine developer Moderna (MRNA) is sinking 9% after Goldman Sachs downgraded the shares to Neutral from Buy. Why Goldman ...

Plus: Moderna’s bird flu vaccine, Obamacare enrollment breaks records, and AstraZeneca’s new breast cancer treatment is FDA ...

RNA vaccine developer Moderna (MRNA) is climbing nearly 5% in early trading today after it was awarded about $590 million by the U.S. government’s Department of Health and Human Services (HHS) on ...

We recently published a list of These 10 Stocks Were Wednesday’s Worst Performers. In this article, we are going to take a ...

SINGAPORE: The updated JN.1 Novavax/Nuvaxovid COVID-19 vaccine will be offered under the national vaccination programme at ...

Fla., praised news that President Donald Trump will reinstate service members expelled for refusing to take the COVID-19 ...

August 26: Moderna Inc (MRNA.O) said on Wednesday it has withheld supply of about 1.63 million doses of its COVID-19 vaccine in Japan after a report of contamination of vials with particulate matter, ...

The US Administration for Strategic Preparedness and Response plans to have “up to 10 million doses of prefilled syringes and multidose vials ... Moderna with $176 million to create mRNA ...

At the time of writing, Moderna had not as yet responded to enquiries about its intentions surrounding its Covid-19 vaccine, Spikevax. Vertex's gene-editing therapy for sickle cell disease ...

Less than a year after China identified the virus, health authorities in the U.S. and Britain cleared vaccines made by Pfizer and Moderna ... but also vials for testing and other supplies ...